chess grandmasters show the same longevity advantage as elite athletes.

"the drug must be administered at the right time point during development," he said..

lupin makes impairment provision for gavis

..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...: "arise: a phase 3 randomized trial of erenumab for episodic migraine."..

"we were quite surprised to find there were no significant differences," says study author.